Build a Better Process
Stock Risk Measures for Eli Lilly & Co
A quantitative factor review, as of September 30, 2020.
- Company Info - Description, identity and sector data.
- Share Data - Stock earnings and key dates.
- Market Risk - Beta, size, liquidity and momentum measures.
- Financial Risk - Earnings and dividends.
Updated: October 01, 2020
See how we arrive at an overall risk score of
for LLY below.
An ad-free and cookie-free webpage by FactorPad
LLY Risk Report
Our quantitative data points are meant to provide a high-level understanding of
factors in equity risk models for Eli Lilly & Co. Portfolio managers use these
models to forecast risk, optimize portfolios and review performance.
We show how LLY stock compares to 2,000+ US-based stocks, and to
peers in the Health Technology sector and Pharmaceuticals: Major industry.
Please do not consider this data as investment advice. Data is downloaded from
sources we deem reliable, but errors may occur.
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
- Symbol: LLY
- FactorPad FPID: f96xmx
- SEC CIK: 0000059478
- Share Class FIGI: BBG001S5STL8
- Location: Indianapolis, IN US
- Web: http://www.lilly.com
- Employees: 33,625
Sector and Industry
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
- SIC Code: 2834
Shares and Float
- Shares Outstanding: 956,470,000
- Shares Trading: 793,636,721
- Percent Trading: 83.0 %
Earnings and Dividends
- Trailing 12-month earnings: 6.17
- Next earnings date: 2020-10-27
- Dividends in last 12 months: 2.77
- Ex-dividend date: 2020-08-13
Market Risk Measures
Many of the following risk metrics are standardized and transformed into
quantitative factors in institutional-level risk models.
Rankings below represent percentiles from 1 to 100, with 1 being the lowest
rating of risk.
Stocks with higher beta exhibit higher sensitivity to the ups and downs
in the market. (↑↑)
Beta: 0.74 |
Stocks with higher market capitalization often have lower risk. (↑↓)
Market Capitalization: $141,576,689,400 |
Higher average daily dollar volume over the past 30 days implies lower
liquidity risk. (↑↓)
Daily Dollar Volume: $506,082,719 |
Higher price momentum stocks, aka recent winners, equate to lower risk for many
Stock Price Change (1-Year): 33.4% |
Financial Risk Measures
Style risk factors often include measures of profitability and payout levels.
Companies with higher earnings generally provide lower risk. (↑↓)
Earnings Yield (E/P): 4.23% |
Companies with higher dividend yields, if sustaintable, are perceived to
have lower risk. (↑↓)
Dividend Yield (D/P): 1.87% |
LLY stock risk
ELI LILLY & CO stock beta
LLY risk report
LLY risk analysis
ELI LILLY & CO credit risk
LLY liquidity risk
LLY systematic risk
LLY specific risk
ELI LILLY & CO volatility
LLY financial ratio
This is a new resource, spread the word, tell a friend